275 related articles for article (PubMed ID: 24009234)
1. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.
Perry AM; Warnke RA; Hu Q; Gaulard P; Copie-Bergman C; Alkan S; Wang HY; Cheng JX; Bacon CM; Delabie J; Ranheim E; Kucuk C; Hu X; Weisenburger DD; Jaffe ES; Chan WC
Blood; 2013 Nov; 122(22):3599-606. PubMed ID: 24009234
[TBL] [Abstract][Full Text] [Related]
2. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.
Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q
Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661
[TBL] [Abstract][Full Text] [Related]
3. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
Wang X; Ng CS; Chen C; Yu G; Yin W
Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
[TBL] [Abstract][Full Text] [Related]
4. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
van Vliet C; Spagnolo DV
Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
[TBL] [Abstract][Full Text] [Related]
5. Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract.
Kohri M; Tsukasaki K; Akuzawa Y; Tanae K; Takahashi N; Saeki T; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Arai E; Arai S; Asou N
Leuk Res; 2020 Apr; 91():106336. PubMed ID: 32151888
[TBL] [Abstract][Full Text] [Related]
6. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.
Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC
Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618
[TBL] [Abstract][Full Text] [Related]
7. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
Wang XG; Yin WH; Wang HY
Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
[TBL] [Abstract][Full Text] [Related]
8. A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma.
McElroy MK; Read WL; Harmon GS; Weidner N
Ann Diagn Pathol; 2011 Oct; 15(5):370-5. PubMed ID: 20952278
[TBL] [Abstract][Full Text] [Related]
9. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case.
Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S
BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological features of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a report of five cases].
Shao SH; Gu HY; Lin DL; Shi HL; Zhang YJ; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):762-766. PubMed ID: 31594039
[No Abstract] [Full Text] [Related]
11. Indolent peripheral T-cell lymphoma involving the gastrointestinal tract.
Leventaki V; Manning JT; Luthra R; Mehta P; Oki Y; Romaguera JE; Medeiros LJ; Vega F
Hum Pathol; 2014 Feb; 45(2):421-6. PubMed ID: 24439229
[TBL] [Abstract][Full Text] [Related]
12. T-cell LPD of the GIT: first do no harm.
Said J
Blood; 2013 Nov; 122(22):3548-50. PubMed ID: 24263952
[TBL] [Abstract][Full Text] [Related]
13. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
14. Recurrent
Sharma A; Oishi N; Boddicker RL; Hu G; Benson HK; Ketterling RP; Greipp PT; Knutson DL; Kloft-Nelson SM; He R; Eckloff BW; Jen J; Nair AA; Davila JI; Dasari S; Lazaridis KN; Bennani NN; Wu TT; Nowakowski GS; Murray JA; Feldman AL
Blood; 2018 May; 131(20):2262-2266. PubMed ID: 29592893
[No Abstract] [Full Text] [Related]
15. Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract.
Freiche V; Cordonnier N; Paulin MV; Huet H; Turba ME; Macintyre E; Malamut G; Cerf-Bensussan N; Molina TJ; Hermine O; Bruneau J; Couronné L
Lab Invest; 2021 Jun; 101(6):794-804. PubMed ID: 33692440
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
Soderquist CR; Bhagat G
Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
[TBL] [Abstract][Full Text] [Related]
17. Indolent small intestinal CD4+ T-cell lymphoma is a distinct entity with unique biologic and clinical features.
Margolskee E; Jobanputra V; Lewis SK; Alobeid B; Green PH; Bhagat G
PLoS One; 2013; 8(7):e68343. PubMed ID: 23861889
[TBL] [Abstract][Full Text] [Related]
18. Lymphoproliferative Disorders of the Gastrointestinal Tract.
Skinnider BF
Arch Pathol Lab Med; 2018 Jan; 142(1):44-52. PubMed ID: 28829152
[TBL] [Abstract][Full Text] [Related]
19. Oral manifestation of indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: A potential diagnostic pitfall.
Saggini A; Baciorri F; Di Prete M; Zizzari AG; Anemona L
J Cutan Pathol; 2020 May; 47(5):494-496. PubMed ID: 32003865
[No Abstract] [Full Text] [Related]
20. Genetic and phenotypic characterization of indolent T-cell lymphoproliferative disorders of the gastrointestinal tract.
Soderquist CR; Patel N; Murty VV; Betman S; Aggarwal N; Young KH; Xerri L; Leeman-Neill R; Lewis SK; Green PH; Hsiao S; Mansukhani MM; Hsi ED; de Leval L; Alobeid B; Bhagat G
Haematologica; 2020 Jul; 105(7):1895-1906. PubMed ID: 31558678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
